Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review

SIMPLE SUMMARY: There is a wide range of choices for combining PD-1/PD-L1 checkpoint inhibitors with other measures in treating tumors, but certain choices of regimens are still controversial. We aimed to investigate the therapeutic efficacy and potential side effects of combination therapy with ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yiru, Yao, Qigu, Pan, Yong, Fang, Xinru, Xu, Haoying, Zhao, Tingxiao, Zhu, Guangqi, Jiang, Tianan, Li, Shibo, Cao, Hongcui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913120/
https://www.ncbi.nlm.nih.gov/pubmed/36765640
http://dx.doi.org/10.3390/cancers15030682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913120/
https://www.ncbi.nlm.nih.gov/pubmed/36765640
http://dx.doi.org/10.3390/cancers15030682

Ejemplares similares